how covid-19 increased decentralized clinical trial adoption | greg licholai, pra health sciences
Published 3 years ago • 7.2K plays • Length 19:55Download video MP4
Download video MP3
Similar videos
-
6:48
how reliable is the data from decentralized clinical trials?
-
11:25
the future of virtual clinical research - brad pruitt, executive medical director, icon
-
15:47
virtual clinical trials how apple watch & j&j changed the paradigm - greg licholai, md
-
6:38
when should you incorporate virtual components into your trial protocols?
-
11:13
coronavirus in context: how will covid-19 impact clinical trials and health care? | webmd
-
3:18
part 1 of 5: decentralized clinical trial products #peakmatrix® assessment 2021 | #virtualtrials
-
18:12
effects of an unpredictable pandemic on clinical trials and the need for virtualization - medidata
-
17:27
how clinical trials work: covid-19 and beyond
-
59:29
clinical trials from home? how a decentralised approach puts patients at the centre.
-
8:43
effect of covid-19 on the clinical trials landscape
-
4:01
how to leverage data and technology to promote clinical trial diversity
-
1:20
why should you participate in a covid-19 study | ucla health clinical trials
-
7:34
nlp for healthcare: applying nlp on demand to the covid-19 outcomes research dataset cord-10
-
1:35
a global collaboration to equitable access to new covid-19 diagnostics, therapeutics and vaccines.
-
1:41:05
evolution of clinical trials -what next
-
4:36
covid-19 as a catalyst for the adoption of real-world evidence
-
12:50
minimize the impact of covid-19 on your clinical trials
-
39:27
innovative clinical trials for covid-19
-
7:14
what are we doing to increase representation in clinical trials?